Michael A. Frölich
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Michael A. Frölich has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Timothy J. Ness
Department of Anesthesiology and Perioperative Medicine, University of Alabama at Birmingham, Birmingham, AL, USA
3 shared publications Kui Zhang
Associate Professor, Department of Biostatistics
2 shared publicationsA. Esame
1 shared publication- Alan Thevenet N. Tita
Department of Obstetrics and Gynecology University of Alabama at Birmingham Birmingham Alabama USA
1 shared publication Alice Esame
Medical Student, Howard University College of Medicine, Washington, D.C.
1 shared publicationAlireza Arabshahi
1 shared publication
Latest Publications
- Open Access
- 1 October 2012
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 117 (4) , 857-867
Quantitative Changes in Regional Cerebral Blood Flow Induced by Cold, Heat and Ischemic Pain
Background: The development of arterial spin labeling methods has allowed measuring regional cerebral blood flow (rCBF) quantitatively and to show the pattern of cerebral activity associated with any state such as a sustained pain state or changes due to a neurotropic drug. Methods: The authors studied the differential effects of three pain conditions in 10 healthy subjects on a 3 Tesla scanner during resting baseline, heat, cold, and ischemic pain using continuous arterial spin labeling. Results: Cold pain showed the greatest absolute rCBF increases in left anterior cingulate cortex, left amygdala, left angular gyrus, and Brodmann area 6, and a significant rCBF decrease in the cerebellum. Changes in rCBF were characteristic of the type of pain condition: cold and heat pain showed increases, whereas the ischemic condition showed a reduction in mean absolute gray matter flow compared with rest. An association of subjects' pain tolerance and cerebral blood flow was noted. Conclusions: The observation that quantitative rCBF changes are characteristic of the pain task used and that there is a consistent rCBF change in Brodman area 6, an area responsible for the integration of a motor response to pain, should provide extremely useful information in the quest to develop an imaging biomarker of pain. Conceivably, response in BA6 may serve as an objective measure of analgesic efficacy.
- 1 October 2012
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 117 (4) , 857-867
Open AccessQuantitative Changes in Regional Cerebral Blood Flow Induced by Cold, Heat and Ischemic Pain
Background: The development of arterial spin labeling methods has allowed measuring regional cerebral blood flow (rCBF) quantitatively and to show the pattern of cerebral activity associated with any state such as a sustained pain state or changes due to a neurotropic drug. Methods: The authors studied the differential effects of three pain conditions in 10 healthy subjects on a 3 Tesla scanner during resting baseline, heat, cold, and ischemic pain using continuous arterial spin labeling. Results: Cold pain showed the greatest absolute rCBF increases in left anterior cingulate cortex, left amygdala, left angular gyrus, and Brodmann area 6, and a significant rCBF decrease in the cerebellum. Changes in rCBF were characteristic of the type of pain condition: cold and heat pain showed increases, whereas the ischemic condition showed a reduction in mean absolute gray matter flow compared with rest. An association of subjects' pain tolerance and cerebral blood flow was noted. Conclusions: The observation that quantitative rCBF changes are characteristic of the pain task used and that there is a consistent rCBF change in Brodman area 6, an area responsible for the integration of a motor response to pain, should provide extremely useful information in the quest to develop an imaging biomarker of pain. Conceivably, response in BA6 may serve as an objective measure of analgesic efficacy.
- Open Access
- 1 August 2012
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 117 (2) , 302-308
What Factors Affect Intrapartum Maternal Temperature? A Prospective Cohort Study
Background: In recent years, several reports have indicated that maternal temperature elevations during labor may also be observed in the absence of an infection. Presumed noninfectious causes of maternal temperature elevations include epidural analgesia, endogenous heat production generated by the contracting uterus, and delivery in an overheated room. To investigate the potential causes of noninfectious maternal temperature changes during labor, we conducted a prospective cohort study in women scheduled for labor induction. Methods: We recorded hourly oral temperatures from admission to delivery. We calculated whether temperature changed during labor in 81 women. We then determined if body mass index, and duration of labor, or time from rupture of amniotic sac to delivery, or oxytocin dose, would affect maternal temperature. To evaluate the possible role of epidural analgesia, we compared the temperature slope before and after starting epidural analgesia. Results: We observed an overall significant linear trend of temperature over time with an estimated temperature slope of +0.017°C/h (P = 0.0093). Patients with a positive temperature trend had also a significantly longer time from rupture of membranes to delivery (P = 0.0077) and a higher body mass index (P = 0.0067). Epidural analgesia had no effect on the temperature trend. Conclusions: In our cohort of patients, there was an overall significant linear trend of temperature over time after correcting for heterogeneity among patients. Temperature increase was associated with higher body mass index values and longer time from rupture of membranes to delivery. Epidural analgesia had no effect on maternal temperature.
- 1 August 2012
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 117 (2) , 302-308
Open AccessWhat Factors Affect Intrapartum Maternal Temperature? A Prospective Cohort Study
Background: In recent years, several reports have indicated that maternal temperature elevations during labor may also be observed in the absence of an infection. Presumed noninfectious causes of maternal temperature elevations include epidural analgesia, endogenous heat production generated by the contracting uterus, and delivery in an overheated room. To investigate the potential causes of noninfectious maternal temperature changes during labor, we conducted a prospective cohort study in women scheduled for labor induction. Methods: We recorded hourly oral temperatures from admission to delivery. We calculated whether temperature changed during labor in 81 women. We then determined if body mass index, and duration of labor, or time from rupture of amniotic sac to delivery, or oxytocin dose, would affect maternal temperature. To evaluate the possible role of epidural analgesia, we compared the temperature slope before and after starting epidural analgesia. Results: We observed an overall significant linear trend of temperature over time with an estimated temperature slope of +0.017°C/h (P = 0.0093). Patients with a positive temperature trend had also a significantly longer time from rupture of membranes to delivery (P = 0.0077) and a higher body mass index (P = 0.0067). Epidural analgesia had no effect on the temperature trend. Conclusions: In our cohort of patients, there was an overall significant linear trend of temperature over time after correcting for heterogeneity among patients. Temperature increase was associated with higher body mass index values and longer time from rupture of membranes to delivery. Epidural analgesia had no effect on maternal temperature.
- 30 June 2012
- Published by Springer Nature in Archives of Gynecology and Obstetrics
- Vol. 286 (5) , 1335-1336
Artifactual severe thrombocytopenia in a pregnant patient
- 30 June 2012
- Published by Springer Nature in Archives of Gynecology and Obstetrics
- Vol. 286 (5) , 1335-1336
Artifactual severe thrombocytopenia in a pregnant patient
- 28 October 2011
- Published by BMJ in BMJ Evidence-Based Medicine
- Vol. 17 (3) , 83-84
Oxytocin for slow progress in the first stage of spontaneous labour is not associated with different rates of caesarean or assisted delivery compared with no treatment or delayed use in second stage
Bugg et al discuss the important question of whether labour augmentation with oxytocin would decrease the duration of labour. This treatment is part of active management of labour, a concept that also includes objective diagnosis of labour and early amniotomy.1 Slow progress of labour or ineffective uterine activity has been quoted as the cause of caesarean sections in 35% of women with cephalic pregnancies2 and as a possible cause for an increase in maternal and foetal morbidity.3 4 Several types of abnormal labour can be studied.
- 28 October 2011
- Published by BMJ in BMJ Evidence-Based Medicine
- Vol. 17 (3) , 83-84
Oxytocin for slow progress in the first stage of spontaneous labour is not associated with different rates of caesarean or assisted delivery compared with no treatment or delayed use in second stage
Bugg et al discuss the important question of whether labour augmentation with oxytocin would decrease the duration of labour. This treatment is part of active management of labour, a concept that also includes objective diagnosis of labour and early amniotomy.1 Slow progress of labour or ineffective uterine activity has been quoted as the cause of caesarean sections in 35% of women with cephalic pregnancies2 and as a possible cause for an increase in maternal and foetal morbidity.3 4 Several types of abnormal labour can be studied.
- 1 May 2011
- Published by Elsevier in Journal of Clinical Anesthesia
- Vol. 23 (3) , 218-223
Hemodynamic characteristics of midazolam, propofol, and dexmedetomidine in healthy volunteers
- 1 May 2011
- Published by Elsevier in Journal of Clinical Anesthesia
- Vol. 23 (3) , 218-223
Hemodynamic characteristics of midazolam, propofol, and dexmedetomidine in healthy volunteers
- 1 November 2010
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 111 (5) , 1333-1334
Society for Obstetric Anesthesia and Perinatology 2010 Meeting Summary
- 1 November 2010
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 111 (5) , 1333-1334
Society for Obstetric Anesthesia and Perinatology 2010 Meeting Summary
- 1 August 2010
- Published by Elsevier in Neuroscience Letters
- Vol. 480 (1) , 12-15
Temporal characteristics of cold pain perception
- 1 August 2010
- Published by Elsevier in Neuroscience Letters
- Vol. 480 (1) , 12-15
Temporal characteristics of cold pain perception
- 1 May 2010
- Published by BMJ in Regional Anesthesia & Pain Medicine
- Vol. 35 (3) , 249-254
Intravenous Lidocaine Reduces Ischemic Pain in Healthy Volunteers
Background and Objectives: Lidocaine, a local anesthetic and antiarrhythmic drug that alters depolarization in neurons by blocking the fast voltage-gated sodium (Na+) channels in the cell membrane, is used for regional anesthesia, as antiarrhythmic drug, and as analgesic for various painful conditions. It is unclear whether monotherapy with intravenous lidocaine has an analgesic effect in healthy individuals. To address this important question, we studied pain perception before, during, and after the administration of intravenous lidocaine in 16 human volunteers. Our hypothesis was that lidocaine, administered as a short intravenous infusion, does not have an analgesic effect in healthy volunteers. Methods: Sixteen healthy human volunteers received systemic lidocaine at plasma concentration 2 mg/mL using a computer-assisted infusion. Participants underwent a series of sensory tests-thermal, electrical, and ischemic pain and normal pinprick sensation-at baseline, during, and 30 mins after administration of a 20-min lidocaine infusion at a 2 mg/mL effect site concentration. Results: We found a sustained decrease in ischemic pain ratings and a limited analgesic effect for electrical pain, whereas thermal pain and normal sensation did not change. Conclusions: The observed sustained analgesic effect of systemic lidocaine in the ischemic pain model suggests that lidocaine may be used to treat acute pain.
- 1 May 2010
- Published by BMJ in Regional Anesthesia & Pain Medicine
- Vol. 35 (3) , 249-254
Intravenous Lidocaine Reduces Ischemic Pain in Healthy Volunteers
Background and Objectives: Lidocaine, a local anesthetic and antiarrhythmic drug that alters depolarization in neurons by blocking the fast voltage-gated sodium (Na+) channels in the cell membrane, is used for regional anesthesia, as antiarrhythmic drug, and as analgesic for various painful conditions. It is unclear whether monotherapy with intravenous lidocaine has an analgesic effect in healthy individuals. To address this important question, we studied pain perception before, during, and after the administration of intravenous lidocaine in 16 human volunteers. Our hypothesis was that lidocaine, administered as a short intravenous infusion, does not have an analgesic effect in healthy volunteers. Methods: Sixteen healthy human volunteers received systemic lidocaine at plasma concentration 2 mg/mL using a computer-assisted infusion. Participants underwent a series of sensory tests-thermal, electrical, and ischemic pain and normal pinprick sensation-at baseline, during, and 30 mins after administration of a 20-min lidocaine infusion at a 2 mg/mL effect site concentration. Results: We found a sustained decrease in ischemic pain ratings and a limited analgesic effect for electrical pain, whereas thermal pain and normal sensation did not change. Conclusions: The observed sustained analgesic effect of systemic lidocaine in the ischemic pain model suggests that lidocaine may be used to treat acute pain.
- 1 January 2006
- Published by Springer Nature in Canadian Journal of Anesthesia/Journal canadien d'anesthésie
- Vol. 53 (S1) , 79-85
A single dose of fentanyl and midazolam prior to Cesarean section have no adverse neontal effects
Analgesia and sedation, routinely used as adjunct medications for regional anesthesia, are rarely used in the pregnant patient because of concerns about adverse neonatal effects. In an effort to obtain more information about maternal analgesia and sedation we studied neonatal and maternal effects of iv fentanyl and midazolam prior to spinal anesthesia for elective Cesarean section. In this double-blinded, randomized, placebo-controlled trial, 60 healthy women received either a combination of 1 µg·kg-1 fentanyl and 0.02 mg·kg-1 midazolam intravenously or an equal volume of iv saline at the time of their skin preparation for a bupivacaine spinal anesthetic. Sample size was based on a non-parametric power analysis (power > 0.80 and alpha = 0.05) for clinically important differences in Apgar scores. Fetal outcome measures included Apgar scores, continuous pulse oximetry for three hours, and neurobehavioural scores. Maternal outcomes included catecholamine levels, and recall of anesthesia and delivery. There were no between-group differences of neonatal outcome variables (Apgar score, neurobehavioural scores, continuous oxygen saturation). Mothers in both groups showed no difference in their ability to recall the birth of their babies. Maternal analgesia and sedation with fentanyl (1 µg·kg-1) and midazolam (0.02 mg·kg-1) immediately prior to spinal anesthesia is not associated with adverse neonatal effects. Ľanalgésie et la sédation, complément habituel à ľanesthésie régionale, sont rarement utilisées chez la femme enceinte parce qu’on craint les effets néonatals indésirables. Pour en savoir davantage sur ľanalgésie et la sédation de la mère, nous avons étudié les effets sur la mère et ľenfant du fentanyl et du midazolam iv administrés avant la rachianesthésie pour césarienne. Pour ľétude randomisée, à double insu et contrôlée contre placebo, 60 femmes en santé ont reçu une combinaison intraveineuse de 1 µg·kg-1 de fentanyl et 0,02 mg·kg-1 de midazolam ou un volume égal de solution saline iv au moment de préparer à la rachianesthésie avec bupivacaine. La taille de ľéchantillon reposait sur une analyse de puissance non paramétrique (puissance > 0,80 et alpha = 0,05) pour des différences cliniquement importantes ďindices ďApgar. Les mesures de ľévolution du fœtus comprenaient ľindice ďApgar, la sphygmo-oxymétrie continue pendant trois heures et les scores neurocomportementaux. Ľévaluation de la mère incluait les niveaux de catécholamine et la présence de souvenir de ľanesthésie et de ľaccouchement. Il n’y a pas eu de différence intergroupe des variables mesurées chez le nouveau-né (indice ďApgar, comportement neurologique, mesure continue de la saturation en oxygène). Les mères des deux groupes ont montré la même capacité à se rappeler la naissance de leurs enfants. Ľanalgésie et la sédation maternelles avec du fentanyl (1 µg·kg-1) et du midazolam (0,02 mg·kg-1) administrées immédiatement avant la rachianesthésie ne sont pas associées à des effets néonatals indésirables.
- 1 January 2006
- Published by Springer Nature in Canadian Journal of Anesthesia/Journal canadien d'anesthésie
- Vol. 53 (S1) , 79-85
A single dose of fentanyl and midazolam prior to Cesarean section have no adverse neontal effects
Analgesia and sedation, routinely used as adjunct medications for regional anesthesia, are rarely used in the pregnant patient because of concerns about adverse neonatal effects. In an effort to obtain more information about maternal analgesia and sedation we studied neonatal and maternal effects of iv fentanyl and midazolam prior to spinal anesthesia for elective Cesarean section. In this double-blinded, randomized, placebo-controlled trial, 60 healthy women received either a combination of 1 µg·kg-1 fentanyl and 0.02 mg·kg-1 midazolam intravenously or an equal volume of iv saline at the time of their skin preparation for a bupivacaine spinal anesthetic. Sample size was based on a non-parametric power analysis (power > 0.80 and alpha = 0.05) for clinically important differences in Apgar scores. Fetal outcome measures included Apgar scores, continuous pulse oximetry for three hours, and neurobehavioural scores. Maternal outcomes included catecholamine levels, and recall of anesthesia and delivery. There were no between-group differences of neonatal outcome variables (Apgar score, neurobehavioural scores, continuous oxygen saturation). Mothers in both groups showed no difference in their ability to recall the birth of their babies. Maternal analgesia and sedation with fentanyl (1 µg·kg-1) and midazolam (0.02 mg·kg-1) immediately prior to spinal anesthesia is not associated with adverse neonatal effects. Ľanalgésie et la sédation, complément habituel à ľanesthésie régionale, sont rarement utilisées chez la femme enceinte parce qu’on craint les effets néonatals indésirables. Pour en savoir davantage sur ľanalgésie et la sédation de la mère, nous avons étudié les effets sur la mère et ľenfant du fentanyl et du midazolam iv administrés avant la rachianesthésie pour césarienne. Pour ľétude randomisée, à double insu et contrôlée contre placebo, 60 femmes en santé ont reçu une combinaison intraveineuse de 1 µg·kg-1 de fentanyl et 0,02 mg·kg-1 de midazolam ou un volume égal de solution saline iv au moment de préparer à la rachianesthésie avec bupivacaine. La taille de ľéchantillon reposait sur une analyse de puissance non paramétrique (puissance > 0,80 et alpha = 0,05) pour des différences cliniquement importantes ďindices ďApgar. Les mesures de ľévolution du fœtus comprenaient ľindice ďApgar, la sphygmo-oxymétrie continue pendant trois heures et les scores neurocomportementaux. Ľévaluation de la mère incluait les niveaux de catécholamine et la présence de souvenir de ľanesthésie et de ľaccouchement. Il n’y a pas eu de différence intergroupe des variables mesurées chez le nouveau-né (indice ďApgar, comportement neurologique, mesure continue de la saturation en oxygène). Les mères des deux groupes ont montré la même capacité à se rappeler la naissance de leurs enfants. Ľanalgésie et la sédation maternelles avec du fentanyl (1 µg·kg-1) et du midazolam (0,02 mg·kg-1) administrées immédiatement avant la rachianesthésie ne sont pas associées à des effets néonatals indésirables.